Fundraising Fox

Marizyme

Davenport, US · Nevada corporation

Biotech

Founders & leadership

TB
Terry BrostowinNamed on SEC filing
JS
James SapirsteinNamed on SEC filing
ND
Nicholas DeVitoNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.2M disclosed across 5 rounds · 2018–2023

▶$1MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HearlDirector
  • Michael StewartDirector
  • Steven BrooksExecutive Officer
  • David BarthelExecutive Officer, Director
  • Vithalbhai DhadukExecutive Officer, Director
  • Nilesh PatelDirector
  • Catherine PachukExecutive Officer
  • Terry BrostowinDirector
  • George KovalyovExecutive Officer
  • Julie KampfDirector
  • Harrison RossExecutive Officer
Offering amount
$10M
Amount sold
$1M
Minimum investment
$1K
Sales commissions
$800K
Placement agents
Univest Securities, LLC
First sale
May 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$265.2KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven BrooksExecutive Officer
  • David BarthelExecutive Officer, Director
  • Vithalbhai DhadukExecutive Officer, Director
  • Michael StewartDirector
  • Terry BrostowinDirector
  • Catherine PachukExecutive Officer
  • Julie KampfDirector
  • George KovalyovExecutive Officer
  • William HearlDirector
  • Nilesh PatelDirector
  • Harrison RossExecutive Officer
Offering amount
$265.2K
Amount sold
$265.2K
First sale
Apr 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedNov 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bradley RichmondExecutive Officer
  • Vithalbhai DhadukDirector
  • Steven BrooksExecutive Officer
  • Catherine PachukExecutive Officer
  • Julie KampfDirector
  • William HearlDirector
  • Terry BrostowinDirector
Offering amount
$10M
Amount sold
$1.2M
Sales commissions
$94K
Placement agents
Univest Securities, LLC
First sale
May 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedOct 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald VeryExecutive Officer
  • Steven BrooksExecutive Officer
  • Vithalbhai DhadukDirector
  • Julie KampfDirector
  • Bradley RichmondExecutive Officer
  • Catherine PachukExecutive Officer
  • Terry BrostowinDirector
  • Roger SchallerExecutive Officer
  • William HearlDirector
  • Amy ChandlerExecutive Officer
Offering amount
$10M
Amount sold
$1.2M
Sales commissions
$94K
Placement agents
Univest Securities, LLC
First sale
May 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.6MraisedAug 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Terry BrostowinDirector
  • James SapirsteinExecutive Officer, Director
  • Nicholas DeVitoExecutive Officer
Offering amount
$6M
Amount sold
$5.6M
Placement agents
Univest Securities, LLC
First sale
Sep 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Marizyme raised?
Marizyme has disclosed $9.2M raised across 5 rounds.
Where is Marizyme headquartered?
Marizyme is headquartered in Davenport, US.